109 related articles for article (PubMed ID: 2314777)
1. Potential human teratogenicity of frequently prescribed drugs.
Friedman JM; Little BB; Brent RL; Cordero JF; Hanson JW; Shepard TH
Obstet Gynecol; 1990 Apr; 75(4):594-9. PubMed ID: 2314777
[TBL] [Abstract][Full Text] [Related]
2. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
[TBL] [Abstract][Full Text] [Related]
3. Human teratogens: update 2010.
Holmes LB
Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
[TBL] [Abstract][Full Text] [Related]
4. Evolving knowledge of the teratogenicity of medications in human pregnancy.
Adam MP; Polifka JE; Friedman JM
Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):175-82. PubMed ID: 21766440
[TBL] [Abstract][Full Text] [Related]
5. Prescription of teratogenic medications in United States ambulatory practices.
Schwarz EB; Maselli J; Norton M; Gonzales R
Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
[TBL] [Abstract][Full Text] [Related]
6. Teratogenicity of recently introduced medications in human pregnancy.
Lo WY; Friedman JM
Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765
[TBL] [Abstract][Full Text] [Related]
7. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
[TBL] [Abstract][Full Text] [Related]
8. Use of anesthetic agents in neonates and young children.
Mellon RD; Simone AF; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):509-20. PubMed ID: 17312200
[TBL] [Abstract][Full Text] [Related]
9. Safety of asthma and allergy medications in pregnancy.
Chambers C
Immunol Allergy Clin North Am; 2006 Feb; 26(1):13-28. PubMed ID: 16443141
[TBL] [Abstract][Full Text] [Related]
10. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
11. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
Addis A; Sharabi S; Bonati M
Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation.
Brent RL
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282
[TBL] [Abstract][Full Text] [Related]
14. Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals.
Pole M; Einarson A; Pairaudeau N; Einarson T; Koren G
J Clin Pharmacol; 2000 Jun; 40(6):573-7. PubMed ID: 10868307
[TBL] [Abstract][Full Text] [Related]
15. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
Christian MS; Brent RL
Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
[TBL] [Abstract][Full Text] [Related]
16. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks.
Nahum GG; Uhl K; Kennedy DL
Obstet Gynecol; 2006 May; 107(5):1120-38. PubMed ID: 16648419
[TBL] [Abstract][Full Text] [Related]
18. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
19. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
Webster WS; Brown-Woodman PD; Ritchie HE
Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
[TBL] [Abstract][Full Text] [Related]
20. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
Nava-Ocampo AA; Koren G
Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]